
MEDIHUB announced its participation in the 2024 Taiwan Healthcare Expo, held from December 5th to 8th at Taipei Nangang, alongside its partner AhealthZ.
The Taiwan Healthcare Expo is an annual event where leading corporations gather to showcase cutting-edge medical technologies. It serves as a platform for strategic partnerships and technological exchange and presents an opportunity for domestic companies to strengthen their export competitiveness and expand into the global market.
Founded in 2017, MEDIHUB is a company that developed the digital painless automatic injector i-JECT. It applies a pain-reduction algorithm independently developed through clinical research conducted by professors at Seoul National University Dental Hospital.
The i-JECT has a digital painless anesthesia function and a precise drug infusion feature that prevents drug misuse and side effects. It also incorporates the world's first technology to avoid the injection of anesthetic into blood vessels, aimed at reducing medical errors. This allows medical professionals to minimize human error during manual injections, preventing accidents. Compared to traditional manual syringes, i-JECT relieves pain and ensures precise drug administration, leading to higher patient satisfaction.
MEDIHUB is expanding its product lineup, starting with the i-JECT-ST, an automatic syringe for dental local anesthesia, to replace manual syringes with automatic injectors across all medical fields, including vaccinations, fillers, and drug delivery. Additionally, by forming a partnership with AhealthZ, the company is accelerating its efforts to enter international markets.
At this expo, MEDIHUB plans to showcase its key products at the booth of its partner, AhealthZ, to accelerate its expansion into international markets.